Cargando…
SARS-CoV-2 vaccination in CLL: how often is enough?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773901/ https://www.ncbi.nlm.nih.gov/pubmed/36548017 http://dx.doi.org/10.1182/blood.2022018586 |
| _version_ | 1784855286774759424 |
|---|---|
| author | Mellinghoff, Sibylle C. Cornely, Oliver A. |
| author_facet | Mellinghoff, Sibylle C. Cornely, Oliver A. |
| author_sort | Mellinghoff, Sibylle C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9773901 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | by The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97739012022-12-22 SARS-CoV-2 vaccination in CLL: how often is enough? Mellinghoff, Sibylle C. Cornely, Oliver A. Blood Lymphoid Neoplasia by The American Society of Hematology 2022-12-22 2022-12-22 /pmc/articles/PMC9773901/ /pubmed/36548017 http://dx.doi.org/10.1182/blood.2022018586 Text en © 2022 by The American Society of Hematology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Lymphoid Neoplasia Mellinghoff, Sibylle C. Cornely, Oliver A. SARS-CoV-2 vaccination in CLL: how often is enough? |
| title | SARS-CoV-2 vaccination in CLL: how often is enough? |
| title_full | SARS-CoV-2 vaccination in CLL: how often is enough? |
| title_fullStr | SARS-CoV-2 vaccination in CLL: how often is enough? |
| title_full_unstemmed | SARS-CoV-2 vaccination in CLL: how often is enough? |
| title_short | SARS-CoV-2 vaccination in CLL: how often is enough? |
| title_sort | sars-cov-2 vaccination in cll: how often is enough? |
| topic | Lymphoid Neoplasia |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773901/ https://www.ncbi.nlm.nih.gov/pubmed/36548017 http://dx.doi.org/10.1182/blood.2022018586 |
| work_keys_str_mv | AT mellinghoffsibyllec sarscov2vaccinationincllhowoftenisenough AT cornelyolivera sarscov2vaccinationincllhowoftenisenough |